Loading institutional data...
Loading institutional data...
Held by 198 of 2,417 reporting institutions (95th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DUK | $98.2B | 19.9× | 11.1× | 3.1× | 5.6% | — | 15.7% | 9.6% | 3.7% | 5.0× | 841 |
| EXC | $47.3B | — | 11.6× | 1.9× | 5.3% | — | 11.4% | 9.6% | 3.6% | 5.8× | 374 |
| ED | $42.7B | 20.5× | — | 2.5× | 10.9% | — | 12.0% | 8.4% | 4.0% | — | 428 |
| PCG | $39.7B | 11.2× | — | 1.6× | 2.1% | — | 10.8% | 8.3% | 2.9% | — | 198 |
| WEC | $37.4B | 23.8× | 15.5× | 3.8× | 14.0% | 66.7% | 15.9% | 11.1% | 4.5% | 5.5× | 402 |
| PEG | $36.7B | 17.4× | — | 3.0× | 18.3% | — | 17.3% | 12.4% | 5.3% | — | 367 |
| AEE | $30.5B | 20.6× | — | 3.5× | 15.4% | — | 16.6% | 10.9% | 4.5% | — | 234 |
| CMS | $21.8B | 19.7× | 13.2× | 2.5× | 13.6% | — | 12.5% | 11.7% | 3.8% | 6.0× | 215 |
| NI | $21.5B | 22.9× | 7.4× | 3.3× | 23.5% | — | 14.3% | 9.8% | 9.1% | 0.2× | 208 |
| EVRG | $19.7B | 23.3× | 13.3× | 3.3× | 2.0% | — | 14.4% | 8.4% | 3.6% | 5.4× | 258 |
| LNT | $18.3B | 22.5× | 15.9× | 4.2× | 9.6% | 85.7% | 18.6% | 11.0% | 4.2% | 6.1× | 225 |
| NWE | $4.9B | 26.9× | 14.2× | 3.0× | 6.4% | — | 11.2% | 6.3% | 2.9% | 5.8× | 73 |
| AVA | $3.1B | 15.7× | 5.5× | 1.6× | 1.3% | — | 9.8% | 7.1% | 6.2% | 0.6× | 80 |
| UTL | $1.0B | 18.5× | — | 1.9× | 8.3% | — | 9.4% | 8.2% | 3.4% | — | 48 |
| GNE | $431M | 18.2× | 8.2× | 0.9× | 18.1% | 24.8% | 4.8% | 9.6% | 9.2% | -6.8× | 15 |
Peers = companies sharing PCG's sector (Electric & Other Services Combined) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$3.07B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.93B 100.0% | $24.42B 100.0% | $24.43B 100.0% | $21.68B 100.0% | $20.64B 100.0% | $18.47B 100.0% | $17.13B 100.0% | $16.76B 100.0% | $17.14B 100.0% | $17.67B 100.0% |
| Operating Income | $4.75B 19.0% | $4.46B 18.3% | $2.67B 10.9% | $1.84B 8.5% | $1.88B 9.1% | $1.75B 9.5% | -$10.09B -58.9% | -$9.70B -57.9% | $2.90B 17.0% | $2.08B 11.8% |
| Interest Expense | $3.03B 12.1% | $3.05B 12.5% | $2.85B 11.7% | $1.92B 8.8% | $1.60B 7.8% | $1.26B 6.8% | $934.0M 5.5% | $929.0M 5.5% | $888.0M 5.2% | $829.0M 4.7% |
| Interest & Investment Income | $520.0M 2.1% | $604.0M 2.5% | $606.0M 2.5% | $162.0M 0.7% | $20.0M 0.1% | $39.0M 0.2% | $82.0M 0.5% | $76.0M 0.5% | $31.0M 0.2% | $23.0M 0.1% |
| Other Income (Expense), net | $182.0M 0.7% | $300.0M 1.2% | $272.0M 1.1% | $394.0M 1.8% | $457.0M 2.2% | $483.0M 2.6% | $250.0M 1.5% | $424.0M 2.5% | $123.0M 0.7% | $188.0M 1.1% |
| Pretax Income | $2.42B 9.7% | $2.31B 9.5% | $699.0M 2.9% | $476.0M 2.2% | $748.0M 3.6% | -$942.0M -5.1% | -$11.04B -64.5% | -$10.13B -60.4% | $2.17B 12.7% | $1.46B 8.3% |
| Income Tax Expense | -$280.0M -1.1% | -$200.0M -0.8% | -$1.56B -6.4% | -$1.34B -6.2% | $836.0M 4.0% | $362.0M 2.0% | -$3.40B -19.8% | -$3.29B -19.6% | $511.0M 3.0% | $55.0M 0.3% |
| Net Income | $3K 0.0% | $2K 0.0% | $2K 0.0% | $2K 0.0% | -$102 -0.0% | -$1.30B -7.1% | -$7.64B -44.6% | -$6.84B -40.8% | $1.66B 9.7% | $1.41B 8.0% |
| Per Share | ||||||||||
| EPS (Basic) | $1.18 | $1.16 | $1.09 | $0.91 | -$0.05 | -$1.05 | -$14.50 | -$13.25 | $3.21 | $2.79 |
| EPS (Diluted) | $1.18 | $1.15 | $1.05 | $0.84 | -$0.05 | -$1.05 | -$14.50 | -$13.25 | $3.21 | $2.78 |
| Weighted Avg Shares (Basic) | 2.20B | 2.14B | 2.06B | 1.99B | 1.99B | 1.26B | 528.0M | 517.0M | 512.0M | 499.0M |
| Weighted Avg Shares (Diluted) | 2.20B | 2.15B | 2.14B | 2.13B | 1.99B | 1.26B | 528.0M | 517.0M | 513.0M | 501.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~5.0% on $60.06B of debt.
Cash of $713.0M is below short-term debt of $2.67B — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-28 | Vallejo Alejandro T EVP, Chief People Officer | Tax withholding | 1,029 | $12.96 | $13k |
| 2026-10-23 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 586 | $12.63 | — |
| 2026-09-30 | Larsen John O Director | Plan purchase | 7,500 | $12.20 | $92k |
| 2026-09-30 | Denault Leo P Director | Grant |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 2,653 |
| $12.25 |
| — |
| 2026-09-23 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 597 | $12.41 | — |
| 2026-09-04 | Fugate William Craig Director | 10b5-1 plan sale | 6,500 | $13.76 | $89k |
| 2026-08-21 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 421 | $17.60 | — |
| 2026-08-01 | 2 co-filers EVP, Chief People Officer | Grant | 11,240 | $0.00 | $0 |
| 2026-08-01 | 2 co-filers EVP, Chief People Officer | Tax withholding | 5,086 | $17.38 | $88k |
| 2026-07-23 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 422 | $17.54 | — |
| 2026-07-22 | Cooper Kerry Whorton Director | 10b5-1 plan sale | 1,250 | $18.00 | $23k |
| 2026-07-22 | Santos Marlene Insider | 10b5-1 plan sale | 158,250 | $18.00 | $2.8m |
| 2026-06-30 | Denault Leo P Director | Grant | 1,932 | $16.82 | — |
| 2026-06-23 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 442 | $16.77 | — |
| 2026-06-15 | Peterman Carla J President, EVP Cust&Corp Afrs | 10b5-1 plan sale | 31,786 | $16.68 | $530k |
| 2026-06-05 | 2 co-filers Group filing | Gift | 10,675 | $0.00 | $0 |
| 2026-06-05 | 2 co-filers Group filing | Giftindirect | 10,675 | $0.00 | $0 |
| 2026-06-02 | Cooper Kerry Whorton Director | 10b5-1 plan sale | 1,250 | $16.50 | $21k |
| 2026-05-22 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 449 | $16.49 | — |
| 2026-05-21 | Hernandez Carlos M Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Cooper Kerry Whorton Director | Grant | 17,639 | $0.00 | $0 |
| 2026-05-21 | Cannizzaro Edward G Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Bahri Rajat Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Campbell Cheryl F. Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Denecour Jessica Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Wilson Benjamin Francis Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Smith William Lloyd Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Larsen John O Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Harris Arno Lockheart Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Fugate William Craig Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Ferguson Iii Mark E Director | Grant | 10,948 | $0.00 | $0 |
| 2026-05-21 | Denault Leo P Director | Grant | 10,948 | $0.00 | $0 |
| 2026-04-28 | Glickman Jason M EVP, Strategy and Growth | Open-market sale | 47,264 | $16.35 | $773k |
| 2026-04-28 | Poppe Patricia K Chief Executive Officer | 10b5-1 plan saleindirect | 31,250 | $16.39 | $512k |
| 2026-04-23 | Vallejo Alejandro T EVP, Chief People Officer | Grant | 440 | $16.83 | — |
| 2026-03-31 | Denault Leo P Director | Grant | 1,850 | $17.57 | — |
| 2026-03-23 | 2 co-filers EVP, Chief People Officer | Grant | 426 | $17.39 | — |
| 2026-03-17 | Cooper Kerry Whorton Director | 10b5-1 plan sale | 2,500 | $18.68 | $47k |
| 2026-03-16 | 2 co-filers EVP and CFO | Grant | 144,806 | $0.00 | $0 |
| 2026-03-16 | Peterman Carla J President, EVP Cust&Corp Afrs | 10b5-1 plan sale | 31,786 | $18.31 | $582k |
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 12th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 8% against ROIC 3% — 5% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -57.9 | -58.9 | 9.5 | 9.1 | 8.5 | 10.9 | 18.3 | 19.0 |
| Income Tax | -19.6 | -19.8 | 2.0 | 4.0 | -6.2 | -6.4 | -0.8 | -1.1 |
| Net Income | -40.8 | -44.6 | -7.1 | -0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on PCG: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -4.21pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | -162.9% | 9.4% (today's — no rate published for this year) | -172.3pts |
| FY2020 | 2.8% | 9.4% (today's — no rate published for this year) | -6.6pts |
| FY2021 | 3.0% | 10.3% | -7.3pts |
| FY2022 | 2.5% | 11.0% | -8.5pts |
| FY2023 | 3.3% | 10.9% | -7.7pts |
| FY2024 | 5.2% | 11.2% | -6.0pts |
| FY2025 | 5.1% | 8.6% | -3.5pts |
| Now | 2.9% | 9.4% | -6.4pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 11.8% | 8.0% |
| FY2017 | not reported | 17.0% | 9.7% |
| FY2018 | not reported | -57.9% | -40.8% |
| FY2019 | not reported | -58.9% | -44.6% |
| FY2020 | not reported | 9.5% | -7.1% |
| FY2021 | not reported | 9.1% | -0.4% |
| FY2022 | not reported | 8.5% | 8.4% |
| FY2023 | not reported | 10.9% | 9.2% |
| FY2024 | not reported | 18.3% | 10.3% |
| FY2025 | not reported | 19.0% | 10.8% |
Leverage and buybacks account for 5 points of the 8% return on equity in FY2025. The business earns 3% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
The spread was positive in only 0 of the last 5 years.
Free cash flow has fallen short of reported profit in 3 of the last three years.
Reported free cash flow is -$3.07B; after share-based compensation it is -$3.21B. The difference is a real cost that the cash flow statement adds back.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2.70B | $2.70B |
| Share-based comp | $134M | $2.84B |
| Other non-cash & working capital | $5.88B | $8.72B |
| Operating cash flow | $8.72B | $8.72B |
| Capex | −$11.79B | −$3.07B |
| Free cash flow | −$3.07B | −$3.07B |
| FCF after SBC | −$3.21B | −$3.21B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 7.8% | 46.3% | 38.5 points |
| FY2021 | 11.8% | 24.5% | 12.8 points |
| FY2022 | 5.0% | 12.8% | 7.8 points |
| FY2023 | 12.7% | -22.6% | -35.3 points |
| FY2024 | -0.0% | 8.4% | 8.4 points |
| FY2025 | 2.1% | 2.1% | 0.0 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 27.4 days | not reported | not reported | not reported |
| FY2020 | 37.2 days | not reported | not reported | not reported |
| FY2021 | 41.5 days | not reported | not reported | not reported |
| FY2022 | 44.5 days | not reported | not reported | not reported |
| FY2023 | 30.6 days | not reported | not reported | not reported |
| FY2024 | 33.2 days | not reported | not reported | not reported |
| FY2025 | 33.2 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -14.6 percent |
| FY2020 | 18.2 percent |
| FY2021 | -2.3 percent |
| FY2022 | -1.6 percent |
| FY2023 | -2.0 percent |
| FY2024 | -4.1 percent |
| FY2025 | -4.3 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.